Hgi Capital Management, LLC Cor Medix Inc. Transaction History

Hgi Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.73 - $5.61 $140,739 - $289,212	-51,553 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.83 - $6.24 $5,534 - $9,016	1,445 Added 2.88%	51,553 $283,000
Q4 2021 Feb 14, 2022	SELL	$4.47 - $5.56 $9,601 - $11,942	-2,148 Reduced 4.11%	50,108 $228,000
Q3 2021 Nov 15, 2021	BUY	$4.46 - $7.11 $11,462 - $18,272	2,570 Added 5.17%	52,256 $243,000
Q2 2021 Aug 16, 2021	BUY	$6.05 - $10.09 $99,697 - $166,273	16,479 Added 49.63%	49,686 $341,000
Q1 2021 May 17, 2021	SELL	$6.84 - $17.58 $4,849 - $12,464	-709 Reduced 2.09%	33,207 $332,000
Q4 2020 Feb 04, 2021	BUY	$5.0 - $9.15 $169,580 - $310,331	33,916 New	33,916 $252,000

105

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $353M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Hgi Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hgi Capital Management, LLC with notifications on news.